- Home
- AOS vs ACLX Comparison
AOS vs ACLX Comparison
Compare AOS & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AOS | ACLX |
|---|---|---|
| Founded | 1874 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 6.7B |
| IPO Year | 1994 | 2022 |
Fundamental Metrics
Financial Performance| Metric | AOS | ACLX |
|---|---|---|
| Price | $57.20 | $115.08 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 15 |
| Target Price | $75.44 | ★ $118.17 |
| AVG Volume (30 Days) | 1.4M | ★ 12.1M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | ★ 6.06 | N/A |
| EPS | ★ 0.85 | N/A |
| Revenue | ★ $3,830,200,000.00 | $22,286,000.00 |
| Revenue This Year | $4.51 | $342.39 |
| Revenue Next Year | $3.80 | $170.71 |
| P/E Ratio | $67.07 | ★ N/A |
| Revenue Growth | ★ 0.32 | N/A |
| 52 Week Low | $54.16 | $60.36 |
| 52 Week High | $81.87 | $115.14 |
Technical Indicators
Market Signals| Indicator | AOS | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 42.49 | 79.86 |
| Support Level | $54.16 | $63.46 |
| Resistance Level | $59.47 | N/A |
| Average True Range (ATR) | 1.32 | 0.11 |
| MACD | 0.29 | -0.62 |
| Stochastic Oscillator | 57.91 | 84.28 |
Price Performance
Historical ComparisonAbout AOS A.O. Smith Corporation
A.O. Smith manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments: North America (80% of sales) and rest of world (20% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for the residential and commercial markets, with approximately 36% and 52% market share, respectively. Residential water heaters account for most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered in the mid-1990s.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.